Default version
Site map
Print
February
25
EU INVESTMENT RESCUES COVID-19 PATIENTS
UAB Acrux Cyber Service together with its partners UAB Baltic iTech, the Medical Centre of Anaesthesiology, Intensive Care and Critical Conditions of Public Institution Vilnius University Hospital and the Lithuanian Business Support Agency is implementing the project ‘An artificial intelligence platform for the early detection of lung lesions during artificial lung ventilation’.
‘The effect of mechanical forces of artificial lung ventilation, especially if the method and its settings are not properly selected, can cause dangerous damage to the lung tissue’, says Prof. Dr Saulius Vosylius, an anaesthesiologist - resuscitator Head of the Medical Centre of Anaesthesiology, Intensive Care and Critical Conditions of Vilnius University Hospital. He says that the biggest challenge with positive pressure ventilation is to avoid possible additional lung damage.
The developers of the project have set a goal to reduce the risks of lung damage caused by artificial lung ventilation by applying artificial intelligence methods, classifying data and predicting the signs of lung damage and changes in their parameters.
This is a very important task in treating patients who have Covid-19. Jokūbas Drazdas, the developer of the project and the director of UAB Acrux Cyber Services, was included in the list of thirty people published by the magazine Valstybė (State) who had the biggest positive influence on the economic, social, value and spiritual progress of the Lithuanian State in 2021.
‘The solution emerged before the pandemic, but its benefits were most evident when the need for artificial lung ventilation increased during the pandemic. The idea came from Dr Saulius Vosylius, a respected professor. His team has done a lot of research, although it is true that it was not possible to do more in-depth research. During each exhalation and inhalation, medical devices record over 100 different parameters that are usually not stored anywhere in hospitals. Hospital staff, who care for a large number of patients, are not always able to analyse the huge amount of constantly updated data from the medical equipment, correlate the parameters displayed by all the devices and then adjust the artificial lung ventilation to the individual patient. That’s how we started working together. We are a company specialising in and developing artificial intelligence systems that collect, store and analyse data. The AI system we have applied to artificial lung ventilation can not only make the work of medical staff easier, but can also make the selection of the ventilation technique for the patient much more efficient’, said Drazdas.
He said that the plans have been implemented, the system is working and the project has generated many additional ideas that are gradually being developed and implemented: ‘We are working with our colleagues at Teltonika Telemedic who are developing an artificial lung ventilation machine. The uniqueness of the remote data transmission solution allows us to significantly reduce the cost of patient care while foreign analogues, to our knowledge, are still very expensive’.
The AI platform performs 24-hour continuous analysis of patient data to identify potential lung damage and allows early identification of changes in the patient’s lung condition and dynamics, and can offer solutions for lung-protective ventilation techniques. This system is currently already being used for the treatment of patients at the Republican Vilnius University Hospital.
UAB Acrux Cyber Service has started the process of certifying an innovative system for artificial lung ventilation in the European Union. The technology is already attracting interest from foreign medical equipment manufacturers. The project is supported by the European Union’s Structural Funds under the ‘Experiment’ instrument. The amount of funding available under the contract with the Lithuanian Business Support Agency is EUR 601,872.18.
‘The technology developed by the company is a significant innovation in the field of R&D services, healthcare and biotechnology. It has enormous practical value. It is gratifying that our partners are noticed and appreciated at national level. We wish them success in their future endeavours, and the Agency’s specialists are committed to assisting all the project promoters to ensure that their goals are effectively realised’, says Saulius Merkys, Acting Director of the LBSA.
‘The effect of mechanical forces of artificial lung ventilation, especially if the method and its settings are not properly selected, can cause dangerous damage to the lung tissue’, says Prof. Dr Saulius Vosylius, an anaesthesiologist - resuscitator Head of the Medical Centre of Anaesthesiology, Intensive Care and Critical Conditions of Vilnius University Hospital. He says that the biggest challenge with positive pressure ventilation is to avoid possible additional lung damage.
The developers of the project have set a goal to reduce the risks of lung damage caused by artificial lung ventilation by applying artificial intelligence methods, classifying data and predicting the signs of lung damage and changes in their parameters.
This is a very important task in treating patients who have Covid-19. Jokūbas Drazdas, the developer of the project and the director of UAB Acrux Cyber Services, was included in the list of thirty people published by the magazine Valstybė (State) who had the biggest positive influence on the economic, social, value and spiritual progress of the Lithuanian State in 2021.
‘The solution emerged before the pandemic, but its benefits were most evident when the need for artificial lung ventilation increased during the pandemic. The idea came from Dr Saulius Vosylius, a respected professor. His team has done a lot of research, although it is true that it was not possible to do more in-depth research. During each exhalation and inhalation, medical devices record over 100 different parameters that are usually not stored anywhere in hospitals. Hospital staff, who care for a large number of patients, are not always able to analyse the huge amount of constantly updated data from the medical equipment, correlate the parameters displayed by all the devices and then adjust the artificial lung ventilation to the individual patient. That’s how we started working together. We are a company specialising in and developing artificial intelligence systems that collect, store and analyse data. The AI system we have applied to artificial lung ventilation can not only make the work of medical staff easier, but can also make the selection of the ventilation technique for the patient much more efficient’, said Drazdas.
He said that the plans have been implemented, the system is working and the project has generated many additional ideas that are gradually being developed and implemented: ‘We are working with our colleagues at Teltonika Telemedic who are developing an artificial lung ventilation machine. The uniqueness of the remote data transmission solution allows us to significantly reduce the cost of patient care while foreign analogues, to our knowledge, are still very expensive’.
The AI platform performs 24-hour continuous analysis of patient data to identify potential lung damage and allows early identification of changes in the patient’s lung condition and dynamics, and can offer solutions for lung-protective ventilation techniques. This system is currently already being used for the treatment of patients at the Republican Vilnius University Hospital.
UAB Acrux Cyber Service has started the process of certifying an innovative system for artificial lung ventilation in the European Union. The technology is already attracting interest from foreign medical equipment manufacturers. The project is supported by the European Union’s Structural Funds under the ‘Experiment’ instrument. The amount of funding available under the contract with the Lithuanian Business Support Agency is EUR 601,872.18.
‘The technology developed by the company is a significant innovation in the field of R&D services, healthcare and biotechnology. It has enormous practical value. It is gratifying that our partners are noticed and appreciated at national level. We wish them success in their future endeavours, and the Agency’s specialists are committed to assisting all the project promoters to ensure that their goals are effectively realised’, says Saulius Merkys, Acting Director of the LBSA.
